Monte Rosa Therapeutics Inc - GLUE - stock price prediction, stock price target, analyst ratings from 9 analysts

Monte Rosa Therapeutics Inc has a share price target of US$ 15, revenue growth forecast of 80.2%, and profit growth estimate of 85.8% for FY25, based on top 9 analyst calls.